Wronski SL, Mordin M, Kelley K, Anguiano RH, Classi P, Shen E, Manaker S. The role of noninvasive endpoints in predicting long-term outcomes in pulmonary arterial hypertension. Lung. 2020 Feb;198(1):65-86. doi: 10.1007/s00408-019-00289-2
Montserrat-Capdevila J, Godoy P, Marsal JR, Barbe F, Pifarre J, Alseda M, Ortega M. Overview of the impact of depression and anxiety in chronic obstructive pulmonary disease. Lung. 2017 Feb;195(1):77-85. doi: 10.1007/s00408-016-9966-0
Launois R, Fiestas Navarette L, Ethgen O, Le Moine J, Gatsinga R. Health economic value of an innovation: delimiting the scope and framework of future market entry agreements. J Market Access Health Policy. 2014 Jun;2:24988. doi: 10.3402/jmahp.v2.24988
Lash TL, Johansen MB, Christensen S, Baron JA, Rothman KJ, Hansen JG, Sorensen HT. Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung. 2011 Feb 1;189(1):27-35.
Clarkson TB, Anthony MS, Klein KP. Effects of estrogen treatment on arterial wall structure and function. Drugs. 1984;47(Suppl 2):42-51.